Diebold Nixdorf, Incorporated (DBD) Stock Score, Valuation & Financial Research
Diebold Nixdorf, Incorporated is in the Technology sector and Software - Application industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 41/100.
Quick answer for DBD
Diebold Nixdorf, Incorporated currently has a Wall Street Score of 41/100. The stored market price is $64.91. Its financial score is 39/100. Its valuation score is 16/100. The latest WSS change is +0.4 points. These figures are a research snapshot, not a buy or sell recommendation.
What Diebold Nixdorf, Incorporated does
Diebold Nixdorf, Incorporated focuses its efforts on modernizing global banking and retail interactions through comprehensive automation and digitalization. The company's operations are divided into two main areas: Banking and Retail. In the Banking segment, Diebold Nixdorf provides a wide range of hardware, including advanced cash recycling and dispensing units, intelligent deposit machines, tools for teller automation, kiosk technologies, and robust physical security infrastructure. These are supported by sophisticated software: customer-facing applications that streamline engagement, and powerful back-end platforms designed to manage channel transactions, oversee operations and integration, facilitate omnichannel experiences, monitor endpoints, remotely manage assets, execute customer marketing, handle merchandise, and conduct analytics. The company's banking services are extensive, e
DBD financial snapshot
- Wall Street Score:
- 41/100
- Current price:
- $64.91
- Market capitalization:
- $2.20B
- Revenue:
- $3.87B
- Net income:
- $111.2M
- Free cash flow:
- $263.3M
- Cash:
- $282.4M
- Total debt:
- $1.11B
- EPS:
- 3.11
- P/E ratio:
- 20.9x
- Financial score:
- 39/100
- Valuation score:
- 16/100
- Revenue score:
- 26/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $263.3M, showing positive cash generation.
- The balance sheet shows $282.4M of cash versus $1.11B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is +0.4 points: DBD increased 0.4 points because Capital improved by 2 points.
What the numbers mean
Its current valuation score is 16/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 39/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-17.
How to research DBD
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.